Navigation Links
'Meeting Post-MDG Challenges: Integrating Nutrition and Child Development Interventions'
Date:2/6/2014

NEW YORK, February 6, 2014Today The Sackler Institute for Nutrition Science at the New York Academy of Sciences and UNICEF host a launch event for Every Child's Potential: Integrating Early Childhood Development and Nutrition Interventionsa special volume of Annals of the New York Academy of Sciences. The event focuses on how to optimize and integrate two highly complementary fields: nutrition and child development.

Held at UNICEF headquarters, the event brings together diplomats, policy-makers, and researchers from key institutions with an interest and investment in furthering children's optimal survival, growth, and development. The event comes a day after the 8th session of the Open Working Group on Sustainable Development, which met to shape the post-2015 Millennium Development Goals.

International experts in nutrition and childhood development will present talks on the current state of evidence in integrating interventions (an assessment of overall effectiveness, factors in the success or failure of such interventions, and strategies to bring such interventions to scale), as well as the need to consider early childhood development in the post-2015 development agenda.

Speakers include Dr. Pia Britto (UNICEF), Dr. Mandana Arabi (The Sackler Institute for Nutrition Science), Dr. Rafael Perez-Escamilla (Yale University), Dr. Jane Lucas (consultant at the World Health Organization), Lucy Sullivan (1,000 days), Annals volume editors Dr. Maureen Black (University of Maryland) and Dr. Kathryn Dewey (University of California at Davis), and Annals authors Dr. Michael Georgieff (University of Minnesota), Dr. Sally McGregor (The University College of London), and Dr. Aisha Yousafzai (Aga Khan University). Welcome remarks will be provided by Dr. Nicholas Alipui (UNICEF) and Dr. Werner Schultink (UNICEF).

As World Health Organization Director-General Dr. Margaret Chan points out in her opening Annals commentary ("Investing in earl
'/>"/>

Contact: Diana Friedman
dfriedman@nyas.org
212-298-8645
New York Academy of Sciences
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Bed bugs, stink bugs headline Entomology Meeting in Hartford, Conn.
2. MARC travel award announced for the 2012 ASCI/AAP Joint Meeting
3. GSA North-Central Section Meeting: Change through Time
4. Registration open for the Ecological Society of Americas 2012 Annual Meeting in Portland, Ore.
5. 2012 ARVO Award recipients honored at annual meeting
6. Second Middle East & Africa Osteoporosis Meeting to take place in Jordan
7. DOE Plasma Science Center Annual Meeting at Princeton Plasma Lab
8. 6th Annual Canadian Neuroscience Meeting, Vancouver, May 20-23, 2012
9. European Society of Human Reproduction and Embryology 28th Annual Meeting -- Istanbul
10. Major osteoporosis meeting opens in São Paulo
11. John Theurer Cancer Center presents significant blood cancer research at 2012 ASCO Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2015)... Calif. , July 13, 2015 ... developer of human interface solutions, today announced sampling ... touch and display driver integration (TDDI) product targeting ... the first to combine Synaptics , best-in-class ... proven display driver technology developed in the company,s ...
(Date:7/9/2015)... July 07, 2015 ... addition of the "Biometrics for Banking; Market ... report to their offering. The ... to this growth and the forecast is that ... revenue for companies involved in delivering biometric systems ...
(Date:7/8/2015)... 2015 Summary Pancreatic cancer is the ... fatal, with a mortality rate of 10.9 deaths per ... cancer patients has highlighted a significant need for new ... met by the current market. A highly active ... varying molecule types and mechanisms of action, which provides ...
Breaking Biology News(10 mins):Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3
... attained very promising results on their initial investigations of a ... mass spectrometry of a single drop of blood serum, the ... of the patients tested. The results can be found online ... . "Because ovarian cancer is a disease of ...
... As much as 12 percent of the worlds human-caused greenhouse ... charcoal-like substance made from plants and other organic materials. Thats ... and materials were burned to generate energy, concludes a study ... calculations show that biochar can play a significant role in ...
... marine mosasaur Platecarpus , lived in the Cretaceous Period some ... an eel. That theory is debunked in a new paper published ... of scientists have reconceived the animal,s morphology, or body plan, based ... Los Angeles County. The paper was co-authored by ...
Cached Biology News:Initial trials on new ovarian cancer tests exhibit extremely high accuracy 2Charcoal takes some heat off global warming 2Charcoal takes some heat off global warming 3Charcoal takes some heat off global warming 4Charcoal takes some heat off global warming 5Mosasaur fossil at Natural History Museum of L.A. County re-explores 85-million-year-old sea monster 2
(Date:8/3/2015)... Aug. 3, 2015  ArroGen Group, an integrated ... Fingerprint Molecular Identification™ (FMID) technology Aug. 2-8 at ... Sacramento, Calif. ... enable law enforcement agents, district attorneys and government ... suspects. By analyzing chemical residues on ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... Nine field ... Iowa, Illinois and Indiana. Hosted by the Soil Health Partnership , the field ... lasting environmental benefits while potentially increasing farm productivity and income. , Brent Bible has ...
(Date:8/3/2015)... , Aug. 3, 2015 /PRNewswire/ - RepliCel Life Sciences Inc. ... focused on the development of autologous cell therapies, announced today ... at the InvestMNT conference held in Minneapolis, Minnesota ... local time. Hall,s presentation will highlight RepliCel,s 18-month milestones including ... Europe , clinical data from both RCT-01 ...
(Date:7/31/2015)... ... July 31, 2015 , ... R-Biopharm is proud to announce ... gluten in foods, has been accepted by AOAC International as Official First Action ... Fermented Cereal-Based Products by R5 Competitive ELISA,” based on a specific monoclonal antibody ...
Breaking Biology Technology:ArroGen Previews New Fingerprint Molecular Identification Technology 2Soil Health Field Days Kick Off Throughout Midwest 2Soil Health Field Days Kick Off Throughout Midwest 3RepliCel Presenting at InvestMNT Investor Conference in Minneapolis 2RIDASCREEN® Competitve Gliadin Receives AOAC Official First Action Status 2
... TGH to Enhance Clinical Skills,Development, DENVER, Nov. ... partnership with the University of South Florida (USF) ... Health hospital,partners and for local and national health ... Center is located at Tampa,General Hospital, a major ...
... 10 NeurogesX, Inc.,(Nasdaq: NGSX ), a ... management therapies, announced today that,Anthony DiTonno, President and ... Rodman & Renshaw 10th Annual Healthcare Conference in ... DiTonno and Stephen Ghiglieri,Chief Financial Officer, will also ...
... Company Registered in Switzerland, Will Move its Headquarter ... Various Issues Related to Neovascularisation, - Gene Signal is Working ... Now in Phase III Trials, - Gene Signal Will Present ... the American Academy of Ophtalmologist in Atlanta, USA, the ...
Cached Biology Technology:Medical Simulation Corporation Announces Partnership With University of South Florida 2Medical Simulation Corporation Announces Partnership With University of South Florida 3NeurogesX to Present at Rodman & Renshaw 10th Annual Healthcare Conference 2NeurogesX to Present at Rodman & Renshaw 10th Annual Healthcare Conference 3Gene Signal Enters Phase III Clinical Tests for the Prevention of Corneal Graft Rejection 2Gene Signal Enters Phase III Clinical Tests for the Prevention of Corneal Graft Rejection 3
Any form, any size, any number of mutageneses. ExonBio provides the best service with double sequecing to make sure the success of the mutagenesis....
Loading Buffer...
Request Info...
Request Info...
Biology Products: